Zhongxuan Gui , Yingquan Ye , Yu Li , Zhengting Ren , Nan Wei , Li Liu , Hua Wang , Mei Zhang
{"title":"“构建一种新的癌症相关成纤维细胞相关特征来预测宫颈癌的临床结果和免疫反应”的勘误表[Transl Oncol. 2024;46:102001]","authors":"Zhongxuan Gui , Yingquan Ye , Yu Li , Zhengting Ren , Nan Wei , Li Liu , Hua Wang , Mei Zhang","doi":"10.1016/j.tranon.2025.102499","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48975,"journal":{"name":"Translational Oncology","volume":"61 ","pages":"Article 102499"},"PeriodicalIF":5.0000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Construction of a novel cancer‑associated fibroblast‑related signature to predict clinical outcome and immune response in cervical cancer” [Transl Oncol. 2024;46:102001]\",\"authors\":\"Zhongxuan Gui , Yingquan Ye , Yu Li , Zhengting Ren , Nan Wei , Li Liu , Hua Wang , Mei Zhang\",\"doi\":\"10.1016/j.tranon.2025.102499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":48975,\"journal\":{\"name\":\"Translational Oncology\",\"volume\":\"61 \",\"pages\":\"Article 102499\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2025-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S193652332500230X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S193652332500230X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
Corrigendum to “Construction of a novel cancer‑associated fibroblast‑related signature to predict clinical outcome and immune response in cervical cancer” [Transl Oncol. 2024;46:102001]
期刊介绍:
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.